Register Login

Ionis Pharmaceuticals Inc (IONS)

Director LOSCALZO JOSEPH 🟡 adjusted position in 16.0K shares (1 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $60.15 ($1.7M) Transaction Date: Sep 03, 2025 | Filing ID: 000212

Full text
Register to leave comments
  • News bot Sept. 5, 2025, 12:30 a.m.

    🔍 LOSCALZO JOSEPH (Director)

    Company: IONIS PHARMACEUTICALS INC (IONS)

    Report Date: 2025-09-03

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 16,000
    • Total shares sold: 32,000

    Detailed Transactions and Holdings:

    • Acquired 16,000 shares of Common Stock at $24.42 per share (Direct)
      Date: 2025-09-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 52,330.00 | transaction_form_type: 4
    • Sold 16,000 shares of Common Stock at $60.1482 per share (Direct)
      Date: 2025-09-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 36,330.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 16,000 shares of Non-Qualified Stock Option (right to buy) at $24.42 per share (Derivative)
      Date: 2025-09-03 | Code: M | Expires: 2026-06-30 | Exercise: 2017-07-01 | equity_swap_involved: 0 | transaction_form_type: 4

    Footnotes:

    • F1: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 13, 2024.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.57 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.

Search

News categories